Literature DB >> 22947650

Morbidity and mortality associated with Clostridium difficile ribotype 078: a case-case study.

L Patterson1, M H Wilcox, W N Fawley, N Q Verlander, L Geoghegan, B C Patel, T Wyatt, B Smyth.   

Abstract

The morbidity and mortality associated with Clostridium difficile ribotype 078 were examined by comparison with other known outbreak strains. A healthcare interaction within eight weeks of a positive specimen significantly increased the likelihood of ribotype 078 compared with ribotype 027. Individuals with ribotype 078 also tended to come from community sources, have a hospital stay post specimen similar to ribotype 027 and a lower 30-day mortality, but these differences were not statistically significant. This study generates several hypotheses and a methodological platform to explore this unique profile.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22947650     DOI: 10.1016/j.jhin.2012.07.011

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

Review 1.  An Update on Clostridioides difficile Binary Toxin.

Authors:  Adrián Martínez-Meléndez; Flora Cruz-López; Rayo Morfin-Otero; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Toxins (Basel)       Date:  2022-04-27       Impact factor: 5.075

Review 2.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  To the Editor: Molecular epidemiology of toxigenic Clostridium difficile isolates in Korea.

Authors:  S Y Cho; Y Nam; Y S Soh; T S Park; H J Lee
Journal:  Epidemiol Infect       Date:  2013-12-02       Impact factor: 4.434

4.  Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.

Authors:  Carlos Quesada-Gómez; Diana López-Ureña; Luis Acuña-Amador; Manuel Villalobos-Zúñiga; Tim Du; Rosemayre Freire; Caterina Guzmán-Verri; María del Mar Gamboa-Coronado; Trevor D Lawley; Edgardo Moreno; Michael R Mulvey; Gerly Anne de Castro Brito; Evelyn Rodríguez-Cavallini; César Rodríguez; Esteban Chaves-Olarte
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

5.  Ribotype 078 Clostridium difficile infection incidence in Dutch hospitals is not associated with provincial pig farming: Results from a national sentinel surveillance, 2009-2015.

Authors:  Sofie M van Dorp; Sabine C de Greeff; Céline Harmanus; Ingrid M J G Sanders; Olaf M Dekkers; Cornelis W Knetsch; Greetje A Kampinga; Daan W Notermans; Ed J Kuijper
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

Review 6.  Clostridium difficile infection in the Lao People's Democratic Republic: first isolation and review of the literature.

Authors:  Elaine Cheong; Tamalee Roberts; Sayaphet Rattanavong; Thomas V Riley; Paul N Newton; David A B Dance
Journal:  BMC Infect Dis       Date:  2017-09-21       Impact factor: 3.090

7.  Comparing the epidemiology of community- and hospital-associated Clostridium difficile infections in Northern Ireland, 2012-2016: a population data linkage and case-case study.

Authors:  A Maisa; G Ross; N Q Verlander; D Fairley; D T Bradley; L Patterson
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.

Authors:  Andreas F Widmer; Reno Frei; Ed J Kuijper; Mark H Wilcox; Ruth Schindler; Violeta Spaniol; Daniel Goldenberger; Adrian Egli; Sarah Tschudin-Sutter
Journal:  Emerg Infect Dis       Date:  2020-10       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.